[Efficacy and safety of BTK inhibitor, venetoclax and rituximab in the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma].
Zhonghua Xue Ye Xue Za Zhi
; 44(3): 247-250, 2023 Mar 14.
Article
in Zh
| MEDLINE
| ID: mdl-37356988
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukemia, Lymphocytic, Chronic, B-Cell
/
Antineoplastic Agents
Limits:
Humans
Language:
Zh
Journal:
Zhonghua Xue Ye Xue Za Zhi
Year:
2023
Document type:
Article
Affiliation country:
Publication country:
CHINA
/
CN
/
REPUBLIC OF CHINA